United States · FDA National Drug Code directory
Fexofenadine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62207-623_1d43d4d6-9021-eac7-e063-6294a90ad21a
- Product NDC
- 62207-623
- Form
- TABLET
- Composition / generic term
- Fexofenadine Hydrochloride
- Labeler
- Granules India Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240102
- Source listing expiry
- 20261231
Source-listed ingredients
- FEXOFENADINE HYDROCHLORIDE — 180 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 24 TABLET in 1 CONTAINER (62207-623-41) · 62207-623-41
- 225 TABLET in 1 CONTAINER (62207-623-45) · 62207-623-45
- 90 TABLET in 1 CONTAINER (62207-623-57) · 62207-623-57
- 7 BLISTER PACK in 1 CARTON (62207-623-71) / 10 TABLET in 1 BLISTER PACK · 62207-623-71
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →